language_icon
EN
HI

Aptus Pharma Share price

APPL

185.8

6.00 (3.34%)
Last updated on 13 May, 2026 | 14:53 IST
Today's High

185.80

Today's Low

183.00

52 Week Low

32.32

52 Week High

185.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aptus Pharma Chart

Aptus Pharma Share Key Metrics

Volume
15000.00
Market Cap
123.34 CR
LTQ@LTP
5000@185.80
ATP
183.93
Var Margin
100 %
Circuit Range
170.85-188.75
Delivery %
100 %
Value
27.59 L
ASM/GSM
No
Market Lot
5000

Summary

Aptus Pharma share price stands at ₹185.8 at 13 May, 2026 | 14:53. The stock Aptus Pharma intraday movement has stayed between ₹183.00 and ₹185.80, while on a 52-week basis it has fluctuated from ₹32.32 to ₹185.80.
In terms of trading activity, Aptus Pharma has recorded a volume of 15000 shares. The Aptus Pharma has a market cap of ₹6860000. The stock’s Average Traded Price (ATP) stands at ₹18393, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 5000, 18580.
The Aptus Pharma operates within a circuit range of ₹170.85-188.75 – ₹170.85-188.75, with a Value of ₹27.59 L. The Delivery Percentage for the day is 100%. Additionally, Aptus Pharma currently falls under the No framework, and trades with a market lot size of 5000.

Aptus Pharma Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

43.69

Sector P/B

2.07

Sec. Div. Yield

79.78

Aptus Pharma Resistance and Support

Pivot 179.1

Resistance

First Resistance

180.7

Second Resistance

181.6

Third Resistance

183.2

Support

First Support

178.2

Second Support

176.6

Third Support

175.7

Aptus Pharma Shareholding Pattern

View More
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

72.89%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

27.11%

Others

0%

Total Promoters
MAR '26
72.89%

Aptus Pharma Corporate Actions

DateAgenda
2026-04-27Audited Results
2026-03-24Bonus issue & Others
2025-11-10Half Yearly Results

Aptus Pharma News

Aptus Pharma Ltd - 544529 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aptus Pharma Ltd announced strong FY26 standalone results. Revenue grew 89.59% to Rs.46.71 crores, and net profit increased 49.05% to Rs.4.62 crores. EBIDTA was up 57.73% at Rs.7.50 crores, reflecting robust operational performance and product expansion.
Apr 28 2026 20:04:00

Aptus Pharma Ltd - 544529 - Intimation Of Record Date For Issue Of Bonus Shares

Aptus Pharma set May 12, 2026, as Record Date for its bonus share issue. Eligible shareholders will receive 3 equity shares for every 2 existing shares held, reflecting a 3:2 ratio.
Apr 27 2026 21:04:00

Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On 27Th April, 2026.

Aptus Pharma board approved audited financial results for FY26, reporting ₹461.99 lacs net profit and ₹4,657.46 lacs revenue. The board also approved a 3:2 bonus share issue with the record date set as May 12, 2026.
Apr 27 2026 19:04:00

Aptus Pharma Ltd - 544529 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Aptus Pharma shareholders approved resolutions to increase authorized share capital and issue bonus shares in a 3:2 ratio. This move enhances the capital structure and directly rewards existing shareholders.
Apr 25 2026 19:04:00
Read More

About Aptus Pharma

NSE : 0  
BSE : 544529  
ISIN : INE15XJ01010  

Our Company was originally incorporated as “Aptus Pharma Private Limited” as a private limited company under the provisions of the Companies Act 1956 pursuant to a Certificate of Incorporation dated August 12 2010 issued by the Registrar of Companies Gujarat. Subsequently our Company was converted into a public limited company in accordance with the provisions of the Companies Act 2013 pursuant to a special resolution passed by the shareholders in their extraordinary general meeting held on November 30 2024. A fresh Certificate of Incorporation consequent upon such conversion was issued by the Registrar of Companies Central Processing Centre on December 12 2024 and the name of our Company was changed to “Aptus Pharma Limited.” The Corporate Identification Number of our Company is U24230GJ2010PLC061957.MAJOR EVENTS:2010- Incorporation of our company under the name “Aptus Pharma Private Limited”2011-2013- Commenced operations through four regional headquarters in Gujarat. Launched a portfolio of 25 products targeting essential therapeutic segments.2013–2016- Achieved approximately 33% geographical coverage in Gujarat. Expanded product portfolio to over 50 products catering to both acute and chronic segments.2016–2019- Increased portfolio to over 70 products in response to evolving therapeutic requirements.2019–2022- Extended presence to around 80% of Gujarat including remote areas. Product portfolio grew to over 100 products. Appointed a C&F agent in Ahmedabad and improved logistics infrastructure.2022-2024- Achieved full geographical coverage across Gujarat. Expanded product portfolio to over 175 products. Established three operational divisions: Acute Chronic and OTC. Initiated in-house manufacturing under a loan license arrangement.2024- Converted to a public limited company and changed name to “Aptus Pharma Limited”.

Read More

Aptus Pharma Management

NamePosition
Tejash Maheshchandra HathiManaging Director
Chetan Shantilal LalsetaNon Executive Director
View More

Aptus Pharma Similar Stocks

No Data Found

Aptus Pharma FAQs

The Buying Price of Aptus Pharma share is 185.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Aptus Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aptus Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Aptus Pharma shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Aptus Pharma shares is 0. Useful to assess the stock's value relative to its book value.

To assess Aptus Pharma’s valuation compare Sector P/E, P/B which are 43.69 & 2.07 with sector averages, along with growth rates and financial metrics.

The Market Cap of Aptus Pharma is 123.34 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Aptus Pharma share price is 185.80 & 32.32. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Aptus Pharma belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost